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Purpose: The purpose of the study was to evaluate the use of a sprinting protocol to 
consistently generate exercise-induced muscle damage using an active female 
population, and to observe how jumping metrics and sprint performance change due to 
muscle damage. The study also looked to examine the relationship between sprint 
velocity and player load, and how they relate to repeated sprint ability and lactate 
clearance. By using a field-based EIMD protocol in an active female population, the 
relationship between sprinting, jumping, and physiological markers of fatigue were 
examined. Methods: 10 trained females who routinely participate in sprint-based 
activity performed a repeated sprint protocol consisting of five sets of 8 maximal 
sprints, 20-meters in length, with a 5-meter deceleration zone. Immediately following 
the completion of each set of sprints, the participants performed a series of three 
countermovement jumps on a dual force plate, followed by a 2-minute period of rest 
prior to the start of the next set of sprints. Blood lactate and RPE were assessed 
immediately following the completion of the fifth set, with a repeated lactate test 
performed 3-minutes post and RPE 30-minutes post. Following 24-48 hours of rest, 
participants returned and provided soreness ratings, performed a set of three 20-meter 
maximal sprints with a 5-meter deceleration zone, and 3 countermovement jumps on a 
force plate to determine if the performance declines during the repeated sprint protocol 
are due to fatigue, muscle damage, or a combination of the two. Results: The repeated 
sprint protocol resulted in decreased sprint times and CMJ force metrics that persisted 
for up to 24-48 hours. The protocol also induced a high physiological load, as evidenced 
by elevated lactate values post-exercise and significant soreness in follow-up visits. 
xi 
Conclusion: Through this investigation, it was concluded that the protocol was a valid 
and reliable means of eliciting EIMD, with decrements in both sprinting and jumping 
performance persisting for up to 24-48 hours following the completion of the protocol.
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Chapter 1: Introduction 
Performance in sports requires the ability to quickly make decisions and sustain 
high levels of intensity throughout the duration of the competition (8). Repeated sprint 
sports frequently expose players to situations that demand maximal neuromuscular 
effort and require athletes to perform bouts of intermittent high-intensity muscle 
contraction that can place a large emphasis on eccentric contractions (9, 13). Eccentric 
(lengthening) contractions place a large amount of stress on muscles, with repeated 
contractions leading to exercise-induced muscle damage (EIMD), which is 
characterized by soreness, swelling, and a decreased ability to generate force (7). 
Research has indicated that inability to generate explosive force leads to diminished 
functional performance ability (14) and can be indicative of increased risk of future 
injury (12).  
 EIMD in athletes is observed when performing novel tasks or exercise that 
heavily relies on an eccentric component (14). To evaluate the timeline of recovery 
from EIMD, several different protocols involving jumping or cycle-ergometers have 
been established for inducing EIMD (5). A field-based protocol that may be more 
applicable for intermittent sprint sports was validated by Woolley et al. (14) which used 
repeated sprinting as a test to elicit EIMD and was shown to produce similar results 
when compared to a plyometric muscle damage protocol. Performance of multiple trials 
of a sprinting protocol was able to evaluate the damage response in an active female 
population (7) and accounted for adaptations that limit EIMD (16). The use of multiple 
trials can account for the repeated bout effect (RBE), which serves to attenuate force 
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loss, soreness, and swelling associated with EIMD, allowing the athletes to maintain 
maximal performance during high intensity exercise or competition (10). 
 A countermovement jump (CMJ) test performed on a force plate has been 
shown to be an effective assessment of neuromuscular function due to the in-depth 
analysis of many kinetic and kinematic variables within the jumping motion related to 
both force production and power output. CMJ testing provides long-term decreases in 
performance that are highly repeatable (CV <5%) and is ecologically valid as it is a 
familiar motion for team-sport athletes (23). By examining changes in the timing and 
force production of these variables, EIMD and neuromuscular fatigue have been 
accurately measured in female athletes when compared to traditional isometric MVC 
testing. Traditional jump testing tends to focus on the concentric force output during the 
jump, but including eccentric components can better relate CMJ testing to repeated 
sprinting as an assessment of exercise performance monitoring (23). A single 
countermovement jump is highly practical to repeated sprint activity due to the 
emphasis on the stretch-shortening cycle and has low physiological strain on the body. 
This allows multiple jumps to be used within a testing session and averaged together for 
higher reliability without significantly impacting the protocol (27). Additionally, long-
term monitoring of training load coupled with CMJ testing can be a useful tool for 
observing mechanical adaptations to training and competition related to force 
production and performance.  These changes in jumping related to muscle damage are 
of great value for evaluating events which can increase an athlete’s injury risk (28). 
 Inertial measurement units (IMU) are trunk-mounted devices that are used to 
track an athlete’s movements during sporting events. Utilizing Global Navigation 
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Satellite Systems (GNSS), accelerometers, gyroscopes, and magnetometers, the units 
can identify and quantify sport-related movements (30). IMU’s are used to quantify an 
athlete’s physical exertion beyond simply measuring speed and distance.  They also 
offer the ability to group movement patterns together based on intensity to assess the 
total physical load experienced during a training session or competition (31). Repeated 
use of IMU’s creates a movement profile for an individual, and over time deviations 
from expected movement patterns can be observed, indicating fatigue, muscle damage, 
or an increased risk for future injury associated with high intensity exercise. 
 During high intensity exercise the demand for energy exceeds the body’s ability 
to produce it via aerobic pathways, leading to an increased reliance on glycolysis for 
energy. The insufficient amount of oxygen available results in an increased conversion 
of pyruvate from glycolysis to lactate in an attempt to meet ATP demands. When lactate 
production exceeds the body’s ability to consume it, lactate threshold (LT) is reached, 
leading to decreased blood pH and fatigue (25). Previous research has shown that 
endurance training increases lactate threshold due to an increase in oxidative enzymes, 
which increases lactate clearance (26). However, the relationship between lactate 
clearance to sprint velocity and player load during repeated sprint exercise is currently 
uncharacterized. Coupling blood lactate measurements with player load from an IMU 
could relate repeated sprint ability in female athletes to lactate clearance and maximum 
velocity during sprints. Additionally, the use of blood lactate provides an internal 
quantification of training load, which can be examined across repeated exercise bouts to 
compare exercise intensity. 
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 Previous research has shown that a jumping protocol can elicit EIMD, and a 
field-based sprinting protocol has been validated against jumping protocols to induce 
muscle damage in sport-related tasks (14). Additionally, countermovement jumps have 
been shown to be suitable for evaluating neuromuscular fatigue, as the force plate is 
able to provide a detailed analysis of kinetic and kinematic variables throughout the 
entirety of the jump (23). By performing a repeated sprint protocol coupled with CMJ 
and lactate analysis utilizing an active female population, there is potential to validate 
the field-based protocol and characterize muscle damage in female athletes in sports 
such as soccer, lacrosse, field hockey, and possibly basketball. The previous work that 
has shown a repeated sprint protocol can elicit EIMD (7, 14) and that CMJ testing can 
identify changes in neuromuscular function (23, 27, 28) does not directly relate the two 
tasks within the same testing protocol. Therefore, including CMJ testing intermittently 
throughout a repeated sprint protocol may provide insight into the fatigue-related 
changes to acceleration/deceleration capabilities and the rate of decay of proper 
technique.  Characterizing these changes are critical to proper prescription of training 
loads and determination of correct intermittent recovery periods during match play. 
Purpose of the Study 
 The purpose of the study is to evaluate the use of a sprinting protocol to 
consistently generate exercise-induced muscle damage using an active female 
population, and to observe how jumping metrics and sprint performance change due to 
muscle damage. The study also looks to examine the relationship between sprint 
velocity and player load, and how they relate to repeated sprint ability and lactate 
clearance. By using a field-based EIMD protocol in an active female population, the 
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1. How are changes in countermovement jump metrics and repeated sprint 
performance related in female athletes? 
a. Will the fatigue characteristics of repeated sprinting reflect the changes 
in countermovement jump performance? 
2. What is the relationship between changes in sprint velocity and player load in 
female athletes? 
3. What is the relationship between repeated sprint ability and lactate clearance in 
female athletes? 
Sub-Question 
a. How do subjective damage ratings change following a repeated sprinting 
protocol? 
Hypotheses 
1. There will be a decline in sprint performance during the repeated sprint protocol, 
determined by time increases and velocity decreases in the final sprints of the 
protocol. 
a. There will be a significant relationship between fatigue characteristics of 
repeated sprinting and countermovement jump performance 
2. There will be a significant relationship between sprinting metrics and 
countermovement jump metrics during the repeated sprint protocol. 
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3. Sprint velocity and player load will have a significant relationship with repeated 
sprint ability and lactate clearance. 
Significance of the Study 
 Literature shows that plyometric protocols have been able to consistently 
generate exercise-induced muscle damage, which causes decline in sports performance 
(2,5,7,12,14). Additionally, studies have shown that a sprint protocol with a short 
deceleration phase compared to the acceleration phase is a valid measure to induce 
muscle damage due to a heavy reliance on eccentric contractions (7,14).  However, the 
current research is lacking when focusing specifically on a female population. 
Performing a sprint protocol on well-trained female athletes would have the benefit of 
validating the protocol across genders, as well as comparing the recovery timeline after 
exercise-induced muscle damage between men and women. Most current research in 
EIMD focuses on male populations, and the lack of female research could prove 
beneficial in evaluating potential differences in muscle damage between genders and 
determine training strategies that prevent decline in match performance. Additionally, 
the study could be continued further to examine RBE on heavy eccentric loading to 
establish a training protocol for injury reduction. 
Delimitations 
 Delimitations for this study include: 
1. Participants were active females with a history of repeated sprint sports (18-35 
years). 
2. Participants were recruited from the University of Oklahoma. 
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3. Participants could not participate in the study if they answered “yes” to any 
questions on the PAR-Q, or indicated any reason that they are unable to perform 
high-intensity physical activity. 
4. Participants could not have experienced lower body injury within the previous 
six months.  
5. No exercise took place within 24 hours of testing to prevent residual fatigue 
present during testing. 
6. Caffeine consumption was maintained consistently within the last 24 hours prior 
to each trial. 
Limitations 
 Limitations for this study include: 
1. Previous sporting events could have exposed subjects to eccentric loading, 
diminishing the effects of the EIMD protocol. 
2. No muscle fiber typing was used during the current investigation.  (differences 
in fiber type composition may impact the extent of muscle soreness due to the 
preferential recruitment of Type II muscle fibers during eccentric contractions). 
3. A menstrual cycle history was included to ensure that a normal menstrual cycle 
is occurring, but the phase of menstrual cycle where testing occurs was not 
standardized. 
Assumptions 
1. Subjects were honest when reporting any lower body injuries in the previous six 
months. 
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2. All performance tests, as well as the sprint protocol, were performed with 
maximal effort. 
3. Researchers were experienced with the necessary equipment and collected data 
accurately. 
4. All equipment used in the collection of data was valid and reliable for the 
current study. 
Operational Definitions 
1. Delayed Onset Muscle Soreness (DOMS) – Muscle soreness or pain that 
occurs 24-48 hours after exercise that is either unfamiliar or higher intensity 
than previously performed (1). 
2. Exercise-Induced Muscle Damage (EIMD) – Damage at the cellular level of 
skeletal muscle due to eccentric exercise; characterized by inflammation, 
soreness, and decreased force production (2). 
3. Rate of Force Development (RFD) – An individual’s neuromuscular ability to 
rapidly generate force at the onset of muscular contraction (10). 
4. Repeated Bout Effect (RBE) – A protective effect experienced following 
unaccustomed exercise in order to prevent future muscle damage (16). 
5. Visual Analogue Scale (VAS) – A scale from 0-10 that allows subjects to 
estimate soreness following a muscle damage protocol, with 0 meaning “no 
soreness at all” and 10 meaning “most intense pain imaginable” (12). 
6. Inertial Measurement Units (IMU) – A trunk-mounted device that records a 
person’s location via GNSS, as well as the body’s specific force, orientation, 
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and torque about the center of gravity using an accelerometer, gyroscope, and 
magnetometer. 
7. Neuromuscular Fatigue – The inability to maintain a required force output, due 
to either central or peripheral limitations (24). 
8. Player Load – A measure of an athlete’s work rate through a combination of the 
accelerations produced by three planes of body movement (32). 
















Chapter II: Review of Literature 
Intermittent high-intensity muscle contraction is a requirement to meet the demands of 
sport-specific performance. Meeting this demand requires maximal neuromuscular 
effort (9), which can result in an athlete sustaining damage to their working muscles. 
Exercise-induced muscle damage (EIMD) is a well-studied field, as it is a major 
contributor to athlete soreness and decline in performance (1, 2).  It has been shown that 
trained subjects have a reduced susceptibility to the effects of EIMD, and that 
chronically trained individuals experience a smaller decline in performance (2, 15). 
Repeated trials of eliciting EIMD have shown that the repeated bout effect (RBE) 
lessens decline in rate of force development, which is attributed to increased resistance 
to muscle damage due to eccentric loading (3, 10, 16). 
 Numerous studies have been performed to examine the effects of EIMD on 
athletic performance (2, 5, 7, 12, 14), and a plyometric protocol has been established as 
a valid way to induce EIMD (2, 5). Research has also demonstrated that a protocol 
involving repeated sprinting, which has strong ecological validity for use with field-
based, intermittent sports can elicit EIMD when the deceleration interval is shortened 
compared to the acceleration interval.  This places a larger bias toward eccentric loading 
and has been used in place of a plyometric protocol when studying EIMD (5, 12, 14). 
However, while the criterion validity has been established for a repeated sprint damage 
protocol, research in the area primarily focuses on male athletes, with very little 
research focusing on the damage response of female athletes (7). Additionally, there is 
no research examining how the RBE mechanism differs between genders, and if 
training status can affect response to multiple bouts of EIMD in elite female athletes. It 
11 
is possible that while validating the use of a sprint protocol for EIMD in active female 
athletes, additional insight to gender differences could be observed based on recovery 
time from muscle damage and declines in performance over time. 
Exercise-Induced Muscle Damage and Delayed Onset Muscle Damage 
 Literature has indicated that one of the symptoms indicative of EIMD is delayed 
onset muscle soreness (DOMS) following exercise that is unfamiliar or at a higher 
intensity than an athlete is accustomed to, occurring 24-48 hours after the completion of 
exercise (1, 7, 12, 14). DOMS is categorized as a type I muscle strain, which is 
accompanied by stiffness and a reduced range of motion due to pain during movement. 
The believed mechanism of EIMD leading to DOMS is that large eccentric loading 
during an EIMD protocol causes disruptions during the stretch-shortening cycle of a 
muscle contraction, leading to breakage in the actin-myosin connections and damage of 
muscular protein structures (1, 2). This disconnecting of cross-bridges disturbs the cell 
membrane, increasing intracellular calcium levels and activating calcium-sensitive 
degradative pathways which further the damage to the muscle. An inflammatory 
response to muscle damage transfers fluid into the damaged area, which serves to 
initiate the repair and regeneration process (2, 33). This swelling and pressure within 
the muscle may account for the reduced range of motion and hyperalgesia (2). 
 A study by Thompson et al.  examined the effects of a high-intensity shuttle 
running regimen on muscle soreness, where participants completed a ninety-minute 
protocol that involved movement at a variety of speeds designed to mimic the actions of 
competitive multiple-sprint sports (12). The subjects were assessed based on muscle 
soreness and blood markers for EIMD.  The results indicated significant increases in 
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both the level of muscle soreness and blood plasma markers for muscle damage-related 
metabolites. These findings agree with other work (1, 2, 3) in establishing that DOMS 
can serve as an indicator of EIMD following high intensity exercise. 
Plyometric and Repeated Sprint EIMD Protocols 
 There have been multiple studies indicating that a plyometric damage protocol is 
a valid method of eliciting EIMD (2 ,5, 7, 14). This protocol involves performing ten 
sets of ten countermovement or drop jumps, with emphasis on returning to ninety-
degrees of knee flexion upon landing to exaggerate the eccentric component of the jump 
movement. The exaggerated eccentric motion elicited EIMD in each study performed, 
supporting is use as a reliable protocol for inducing muscle damage (5, 14). However, a 
new protocol for muscle damage involving repeated sprints would have greater 
ecological validity, as the sprints are more specific to the most common movements of 
repeated sprint sports. 
 Several experiments established that a sprinting protocol is sufficient in creating 
EIMD due to the eccentric loading placed on the legs, specifically the hamstrings, 
during repeated sprinting (1, 12, 13). To establish criterion validity for a sprinting 
protocol, Woolley et al. designed a study in which subjects performed both a plyometric 
protocol and a sprint protocol that included a short deceleration zone to emphasize 
eccentric loading, with a four-month washout period between testing sessions to prevent 
RBE interference. The results of the study showed that both protocols successfully 
elicited EIMD, with the sprint protocol generating EIMD to a greater extent than the 
traditional plyometric protocol (14). These findings help establish the agreement 
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between studies and potential use of a sprint protocol for EIMD (1, 12, 13), as well as 
validating the protocol to be used in place of plyometrics (14). 
Repeated Bout Effect 
 The repeated bout effect (RBE) is a protective mechanism used by the body 
after exposure to eccentrically based muscle damage (16). This mechanism occurs 
through changes in neural input, as centrally-mediated force-inhibiting neural 
mechanisms reduce the response to voluntary contraction (11, 14). The result is a 
decreased activation during the stretch-shortening of muscle contraction in order to 
prevent further damage to muscles when additional bouts of eccentric exercise are 
performed (14). To examine the time course of the repeated bout effect, Clarkson et al. 
(3) examined muscle damage and adaptation following an eccentric overload in the 
elbow flexors. The findings of the experiment indicated that rapid adaptation is 
observed between repeated bouts of exercise, as serum creatine kinase activity, an 
indicator of muscle damage, was significantly reduced in repeated trials. However, 
these results seem to differ from a study that measured EIMD in resistance-trained men, 
which used EMG to determine that neural adaptations had not occurred in chronically 
trained individuals (15). While overall ability to recruit muscle fibers decreased in all 
individuals in the study, the researchers determined that EMG activity remained 
unchanged following repeated studies. The author also stated limitations of measuring 
EMG activity following eccentric exercise rather than during the protocol, so further 





 Men and women have been shown to respond differently to exercise, observed 
through both external and cellular examination. Fulco et al. (38) indicated that women 
fatigue at a slower rate than men, and have faster recovery times between muscle 
contractions. At a cellular level, Kellawan et al. (39) demonstrated that exercise 
vasodilation is significantly greater in females following submaximal exercise. For 
measuring responses to high intensity exercise, there are many indirect measures of 
muscle damage with known time courses that are commonly used in place of invasive 
muscle biopsies, including loss of force production, soreness, inflammation, and 
increases in serum muscle protein markers (35). However, conflicting results of studies 
attempting to differentiate muscle damage between genders indicate that the true EIMD 
response between genders is still unknown. 
 A study by Stupka et al. (36) examined the muscle damage response between 
genders following eccentric exercise. The study consisted of measuring blood protein 
markers, direct cellular structure, and an inflammatory response. They found that 
cellular damage was similar between genders, and that creatine kinase activity was not 
significantly correlated to muscle damage. However, the females in the study had an 
attenuated inflammatory response despite the same amount of muscle damage. These 
findings were suggested to be attributed to the antioxidant effects of 17β-estradiol, but it 
was noted that further investigation was needed. Similarly, Sewright et al. determined 
that there were no differences between sexes in soreness or myoglobin levels following 
eccentric exercise, but it was noted that men experienced greater CK levels than 
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women, and women experienced greater strength loss immediately following exercise 
(35). 
 While much research has been done to examine EIMD in sports-related athletics 
(2, 3, 5, 8, 10, 12, 13, 14), these studies focus their attention on a male population. A 
lone study verifies the use of a repeated sprint protocol to elicit EIMD in elite female 
athletes (7), and currently only one study has been published comparing RBE responses 
between genders (20). Hunter (6) determined that women are less fatigable compared to 
their male counterparts, and that the difference is task specific due to how women react 
to certain stressors and intensities compared to males. It is further stated that a possible 
explanation is a lower pain threshold in women, which alters voluntary activation and 
prevents fatigue and muscle damage (6). A separate study by Hunter (37) indicated that 
sex differences in fatigability during dynamic exercise are task and velocity dependent, 
and that the differences are due to contractile mechanisms rather than sex differences in 
voluntary activation. Additional mechanic studies are needed to determine differences 
between genders in EIMD and RBE, and the lack of study in the area of elite female 
athletes provides a large potential for new research. 
Countermovement Jump 
 A countermovement jump (CMJ) is a form of vertical jumping useful for 
assessing neuromuscular function. CMJ tests utilizing a force plate also provide the 
ability to obtain data related to both force and power output, which is valuable for 
monitoring changes in performance over time. CMJ testing is more standardized than 
performance of a simple vertical jump or drop jump and therefore can provide more 
consistent data for analysis (29). When performed properly, CMJ testing on a force 
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plate provides useful data that mimics a common action during repeated sprint sports, 
and places low physiological strain on the participant, allowing it to be repeated without 
significantly contributing to a fatiguing protocol (27).  
 A study performed by Markström and Olsson (40) looked to examine the 
relationship between multiple forms of jumping performance and sprint performance in 
track and field athletes. Through multiple regression analyses, the results indicated that 
CMJ peak force regulated for body weight was a significant predictor of sprint 
performance in track athletes. Furthermore, it was determined that CMJ was the most 
accurate form for jumping performance, as the drop jumps and squat jumps did not 
yield significant results. These findings agree with Gathercole et al. (23), who 
determined that CMJ testing is the most suitable jumping test for monitoring 
neuromuscular function due to high repeatability and sensitivity to changes in 
performance, as well as Cormack et al. (29) who determined that a single CMJ was the 
most reliable method of observing responses to acute and chronic exercise. By 
performing a single countermovement jump in between sets of repeated sprints during 
an EIMD protocol, the sensitivity of metrics such as peak force and rate of force 
development allow a decline curve to be formed, providing valuable insight for future 
prediction of injury risk.  
Inertial Measurement Units 
 A trunk-mounted Inertial Measurement Unit (IMU) is a device used to quantify 
movements of repeated sprint sports to determine a player’s total workload. In addition 
to GNSS data such as speed and distance, IMUs use accelerometers, magnetometers, 
and gyroscopes to capture high intensity movements including jumping, collisions, 
17 
tackling, accelerations, and decelerations, and other physically demanding actions that 
would otherwise be considered low intensity (31). The sum of all movements detected 
by the IMU indicate an athlete’s player load, which can be used to monitor workload 
throughout acute or chronic bouts of exercise (32). Long-term monitoring of a single 
athlete using an IMU can create a movement profile where the device can recognize 
specific motions and movement patterns, and any deviations from normal patterns may 
be indicative of future injury during exercise. Given that a female athlete is 6-8 times 
more likely to experience a non-contact ACL injury than a male performing the same 
exercise (41), monitoring female athletes provides valuable insight for preventing future 
injury due to high intensity exercise.  
 A multifaceted study by Boyd et al. (42) sought to determine the reliability of an 
IMU for use in repeated sprint sports. In a laboratory setting, eight IMUs were attached 
to a hydraulic shaker, and the field-based component consisted of ten athletes each 
wearing two units taped together to ensure that the axes of the accelerometers were 
aligned with each other. The findings of the study were showed that the between- and 
within-device coefficients of variation were less than 2% for all trials of the laboratory 
protocol, and the field-based testing revealed very strong correlation between units 
(r=0.996-0.999). These findings agree with the work of Varley et al (18) who 
determined that GPS units are valid and reliable when compared to a criterion measure 
of laser timing gates. Very strong Pearson correlations (>0.9) indicate that the units are 
valid for use during acceleration, deceleration, and constant velocity for multiple 
speeds. These studies show that a valid and reliable IMU device can be used 
successfully for athlete monitoring. While previous work has used IMU tracking for a 
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female population, these is currently no research that couples an IMU with CMJ 
performance to determine if there is a relationship between force declines and changes 
in movement profiles and player load during a muscle damage protocol.  
Session RPE 
 Session RPE is a concept designed by Foster et al. (43) to quantify the intensity 
of an entire bout of exercise by combining instantaneous RPE with training impulse. 
The use of session RPE allows for all physiological stressors an athlete experiences to 
be combined into a single score, which allows for a simple evaluation of how physically 
demanding a training session or competition is for an athlete (44). Through a series of 
changing exercise modalities, it was determined that session RPE is strongly correlated 
to heart rate during exercise and can be used as an indirect measure of heart rate (43). 
Additionally, Pustina et al. (45) determined that session RPE is a valid indicator of 
training response. Using collegiate soccer players, it was determined that session RPE 
was significantly correlated with distance covered and minutes played during 
competitions, indicating that it can be used to evaluate workloads of participants in 
repeated sprint sports. 
Summary 
 Both plyometric and repeated sprint protocols have been validated for use to 
elicit EIMD based on their heavy eccentric components, and that muscle damage can be 
observed through DOMS, blood plasma markers, and declines in exercise performance 
(2, 5, 7, 12, 14). It is clear that there is a knowledge gap in the effects of muscle damage 
in a female population. While a large amount of research has been done recently to 
study the effects of EIMD, the tendency to focus on a male population needs to be 
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balanced with similar investigations into the female population. A study involving a 
repeated sprint protocol in female athletes could serve to validate the use of the protocol 
for women, and inclusion of countermovement jumping throughout the protocol can 
provide a valuable force decline curve without influencing the results of the sprint 
protocol. Repetition of the protocol over time is also important to study the RBE 
mechanism in women. Lastly, this research would be beneficial for female athletes to 
construct training regimens with the hopes of minimizing declines in performance, 
highlight the time-course and characteristics of recovery, as well as, potentially reduce 
















Chapter III: Methodology 
As previously stated, the purpose of this study was to investigate the utility of a 
repeated sprint protocol as a field-based test for evaluating fitness and fatigue 
characteristics in in female athletes.  This fatiguing protocol was expected to generate 
exercise-induced muscle damage (EIMD), and thus a second purpose was to evaluate 
the recovery process in these active females (e.g. subjective soreness, force production) 
by relating changes in jumping metrics and repeated sprint performance. Lastly, the 
study also looked to examine the relationship between velocity and player load to 
repeated sprint ability and lactate clearance. There is a growing interest in the use of 
microtechnology for tracking athletes in order to assess physical performance and injury 
risk.  However, most of the current use of these technologies has been with male 
athletes in rugby, Australian rules football, soccer, and American football.  Thus, 
acceleration and velocity-based metrics are missing in the female athlete population.  
Additionally, there is little research examining EIMD with a specific focus on females, 
and current literature does not articulate changes in performance at different stages of 
the protocol.  
Participants 
 Based on a power analysis (G*power) using a 1-b of 0.80, 19 participants were 
required, thus up to 25 active women between the ages of 18 and 35 were recruited 
from the University of Oklahoma women’s rugby team, as well as additional active 
females who routinely participate in sprint-based activity to allow for participant 
attrition. Participants could not have been previously exposed to an eccentric loading 
protocol prior to participating in the current study. Participants needed to be free of any 
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lower body injury within the previous six months. All participants consented to 
voluntary participation and were not given compensation for participation in the study. 
All participants were highly active females, capable of performing countermovement 
jumps and repeated sprints. Informed consent, health history status questionnaire, 
rhabdomyolysis screening, PAR-Q, and menstrual history documents were reviewed 
and signed by all subjects prior to the start of testing. All participants were active 
females on the University of Oklahoma women’s rugby team or females participating in 
similar levels of repeated sprint activity, which satisfied the criteria for inclusion (14). 
Inclusion Criteria 
1. Participants were either active female athletes from the University of Oklahoma 
rugby team, or other active females routinely participating in sprint-based 
activity. 
2. Participants had not been previously exposed to an EIMD protocol, 
eccentrically-biased training, and had not experienced significant lower body 
injury within the previous six months. 
3. Participants between 18 and 35 years of age. 
4. Participants experience normal menstrual history. 
Exclusion Criteria 
1. Men, as this study was based on the validation of a sprinting protocol in a 
female population. 
2. Participants who had experienced significant lower body injury in the previous 
six months were not allowed to participate. 
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3. Any participants previously exposed to eccentric loading protocol in order to 
elicit EIMD were excluded. 
4. Any female participants not experiencing a normal menstrual cycle. 
Experimental Design 
 This study employed a within-participant, repeated measures design where each 
participant acted as their own control. Repeated measures testing throughout the 
experimental protocol were used in order to identify a sprint performance and force 
decline curve. A total of nine visits were required to account for all measurements, 
including a familiarization visit prior to data collection. An overview of the protocol can 
be seen in Figure 1 below: 
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Figure 1. Overview of experimental procedures. 
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Data Collection Procedure 
Visit 1: Informed consent and familiarization 
The first visit was used to obtain informed consent, as well as to provide a 
familiarization to all participants in the study. Upon completion of the informed 
consent, health status questionnaire, rhabdomyolysis screening form, PAR-Q, HIPAA, 
and menstrual history documents, participants were fitted to determine the proper size 
of the Catapult compression garment. Height was measured using a Stadi-O-Meter 
(Novel Products, Inc., Rockton, IL, USA), and weight was recorded using the 
ForceDecks (FD4000, NMP ForceDecks Ltd., London, England). A dynamic warmup 
consisting of a 2-3-minute jog, 10 lunges with each leg, 10 body weight squats, and 10 
forward leg swings with each leg was shown to the participants, as it was used before 
each testing session. Participants were then shown the proper mechanics of a 
countermovement jump and asked to perform a series of three jumps on the force plate 
to familiarize the testing procedure. Following jumping, participants were then shown 
the sprinting course and instructed to perform three sprints, consisting of a twenty-meter 
sprint zone and a five-meter deceleration zone. A thirty-second break was given 
between each of the sprints. Once the participants had gone through a familiarization, 
an additional overview of the entire testing protocol was given in order to ensure that 
participants were fully informed about all aspects of the protocol, including lactate 
testing procedures. 
Visits 2, 4, 6, 8: Repeated Sprint Protocol 
 Visits 2 and 4 served to provide baseline measurements for each participant, and 
to observe any changes in force decline due to the repeated bout effect. Visits 6 and 8 
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served as experimental trials for each participant. The testing visits began by obtaining a 
verbal re-consent from the participants, followed by a verbal familiarization of the 
protocol. Participants were fitted for the Catapult OptimEye S5 units (Catapult Sports, 
Melbourne, Australia) which were turned on and allowed to link to a locally positioned 
data acquisition tower before being inserted into the garments. Participants were taken 
through the dynamic warmup previously outlined and performed three 
countermovement jumps to determine proper recovery from the previous session, and 
blood lactate was assessed. If not fully recovered, the participants were given 48 more 
hours of rest in order to ensure that trials began from a consistent starting point. Once 
the Catapult device and radar gun were active, the participants began the sprinting 
protocol, which consisted of five individual sets. Each set consisted of eight, 20-meter 
maximal sprints with a 5-meter deceleration zone. Participants were give 30 seconds of 
rest between each sprint. Participants came to a complete stop within the deceleration 
zone to emphasize eccentric loading. After reaching a complete stop, participants 
walked to the next starting point during the rest period, as shown in Figure 2. 
Immediately following the completion of each set of sprints, the participants completed 
a series of three countermovement jumps, followed by a 2-minute period of rest. Blood 
lactate was assessed immediately following the completion of the fifth set, with a 
repeated test performed 3-minutes post. 
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Figure 2. Schematic of EIMD protocol. 
 
Visits 3, 5, 7, 9: Post-Test Evaluations 
 Following the completion of each repeated sprint protocol (visits 2, 4, 6, 8), 
participants were asked to return for a follow-up visit after 24-48 hours of rest. 
Participants were asked to assess their upper body, lower body, and global soreness 
levels using the VAS. The participants then performed the dynamic warmup previously 
outlined, and performed a total of three 20-meter maximal sprints with 30 seconds of 
rest between each sprint. Participants then performed a series of three countermovement 
jumps. These post-test visits were used to determine if the performance declines during 
the repeated sprint protocol are due to fatigue, muscle damage, or a combination of the 
two.  
Countermovement Jump Metrics 
All jumping metrics were assessed using a countermovement jump. The 
ForceDecks bilateral force plate system and accompanying software was used for 
measurement with a sampling rate of 1000Hz. The ForceDecks has been used in 
previous work to accurately portray countermovement jump power output (17). 
Participants started from a standing position, squatted down to a 90-degree knee angle 
and jumped vertically, keeping their hands on their hips so that power was only 
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generated from the legs. Concentric mean force (ConMF), concentric peak force 
(ConPF), eccentric mean force (EccMF), eccentric peak force (EccPF), peak power 
output (PPr), concentric mean power output (ConMP), eccentric mean power output 
(EccMP), concentric rate of force development (ConRFD), as well as concentric time to 
peak force (ConTPF) and flight time to contraction time ratio (FTCT), were recorded 
during each series of jumps and compared within subjects to characterize the resulting 
fatigue curve.   
Sprint Measurements 
 Sprint performance was measured by means of a 20-meter maximal sprint test 
where sprints were recorded using a Stalker II ATS radar gun (Applied Concepts, 
Plano, TX, USA). Previous literature has shown that the radar gun is an accurate means 
of measuring sprint time and velocity and is often used as the gold standard in 
comparison studies versus timing gate systems (46). A sprint percentage decrement 
score (Sdec) was calculated using the following formula: 
 
Girard et al. (4) found the Sdec calculation was the most valid and reliable method to 
quantify fatigue in tests of repeated-sprint ability. 
Additionally, participants were equipped with inertial motion-analysis units 
(IMU). The IMU’s contain accelerometers and gyroscopes and were utilized to quantify 
linear and angular kinetics associated with the subjects’ movement patterns during 
maximal sprinting. The Catapult device has previously been shown to accurately and 




 Blood lactate was analyzed using a Nova Biomedical Lactate Plus Meter 
(NOVA Biomedical, Waltham, MA, USA) using capillary blood from the participant’s 
finger. The Lactate Plus meter is a valid and reliable instrument for the assessment of 
blood lactate during exercise testing (21). Use of the finger for blood lactate has been 
shown to be a valid measure, as previous work has indicated that there are no statistical 
differences between measurements from the brachial artery and finger capillary blood 
(22). Lactate measurements were obtained by puncturing the skin of the finger with a 
lancet, then using capillary action to draw blood onto the testing strip of the meter. Use 
of lactate measurements provided a method of quantifying internal work load to 
compare across all trials within each participant. 
Perceived Muscle Soreness and Session RPE  
Subjective muscle soreness was reported by the subjects using a visual analogue 
scale (VAS) with a scale of 0-10. The scale consists of a 100mm line that participants 
place a mark on to indicate their level of soreness. The mark is measured as a distance 
from the 0 value to obtain the perceived soreness ranking. A value of 0 indicates “no 
soreness at all” and a value of 10 represents “most intense pain imaginable”. Soreness 
was assessed prior to the start of the sprinting protocol once the subject performed 3 
squats with approximately 90 degrees of flexion and then returned to the standing 
position (12). Measurements of soreness included lower body, upper body, and global 
soreness. The VAS was utilized to ensure that participants did not have any soreness 
prior to the EIMD protocol. 
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The rating of perceived exertion for each sprinting session (sRPE) was recorded 
immediately upon completion of the sprinting protocol, as well as following a 30-
minute washout period once all sprinting sets were completed in a trial.  Session RPE 
was used to help evaluate whether the intensity of each experimental session was 
comparable across trials. 
Research Design 
 The design of this study allowed for research questions to be answered because 
it relied on an active female population without previous eccentric loading training. By 
testing both running and jumping as performance indices, as well as measuring blood 
lactate, the study examined changes in sport-specific tasks, which increases external 
validity of the study. Repetition of the same protocol multiple times allowed for 
buffering due to the repeated bout effect to be observed, and still examine the changes 
in sprint and jumping metrics due to eccentric overload. The first two testing days 
served as a buffer period, while the final two testing days were used to answer the 
research questions. 
Data Management and Analysis 
 All participants in the study were given a subject identification number, which 
was used separately from identifying information when collecting data during the 
protocol. Identifying information was stored in a secure location separate from data so 
that anonymity can be preserved. The data obtained from the visits where the EIMD 
sprint protocols, CMJ performance, player load metrics, and lactate values were each 
analyzed using one-way analysis of variance (ANOVA) with repeated measures. 
Changes in velocity and CMJ performance between EIMD inducing visits (2,4,6,8) and 
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their follow up visits (3,5,7,9), were analyzed using a 4 (trial) x 2 (time) repeated 
measures ANOVA.  Significant interactions and main effects for performance indices 
were then analyzed using post-hoc testing with Bonferroni corrections. Correlations 
between jumping metrics, sprint performance, player load, and blood lactate were also 
performed to identify associations between variables.  To assess the absolute agreement 
of performance across trials, a two-way, mixed effects intraclass correlation (ICC3,1) for 
visits 2, 4, 6, and 8.  Additionally, coefficients of variation (COV) were derived to 
assess the consistency of the relationship between sprint performance means and the 
resulting standard deviation, as well as CMJ-based metrics.  IBM SPSS Statistical 
Software for Macintosh, Version 23 (Armonk, NY, IBM, 2015) was used for all 
analyses.  Statistical significance was set at p £ 0.05.  All data are presented as mean ± 
SD. 
Protocol Overview for Testing Days 
1. Blood lactate measure 
2. Dynamic warmup 
3. Set 1 (8 sprints, 3 countermovement jumps) 
4. Set 2 (8 sprints, 3 countermovement jumps) 
5. Set 3 (8 sprints, 3 countermovement jumps) 
6. Set 4 (8 sprints, 3 countermovement jumps) 
7. Set 5 (8 sprints, 3 countermovement jumps) 




Chapter IV: Results 
The purpose of this study was to evaluate a sprinting protocol as a means of 
generating exercise-induced muscle damage, and to observe changes in jumping metrics 
and sprint performance due to muscle damage. Additionally, the relationship between 
player load and sprint velocity was examined, as well as how they relate to 
physiological markers of fatigue in an active female population. 
Participant Characteristics 
 Nineteen active females enrolled in this study; however, 9 did not complete the 
study due to injuries sustained outside of the study. Most of the participants were 
actively participating in collegiate-level rugby, where they experience high physical 
demands related to collisions, scrums, and abrupt changes of direction. The participants 
were active females aged between 19 and 27 years (mean = 21.70 ± 2.50 years) with a 
history of participation in repeated sprint sports. Participants were free of any 
significant lower body injuries within the previous six months and did not have any 
history of cardiovascular disease. Descriptive data for all participants can be found in 
Table 1, presented as means ± SD. 
Table 1. Subject Characteristics 
Variable Mean ± SD          
n 10                   
Age (years) 21.7±2.5 
Height (cm) 166.3±5.9 
Weight (kg)  68.54±9.2 




One-way repeated measures ANOVA with Bonferroni pairwise comparisons 
were conducted to compare average and peak velocity across experimental sessions and 
post-damage evaluations. No significant differences were observed for average velocity 
(p=0.345) or peak velocity (p=0.685). The average measure ICC3,1 across visit 2, 4, 6, 
and 8 for average velocity was 0.917 with a 95% confidence interval from 0.779 to 
0.977 (F(9,27)=11.015, p<0.001), whereas the ICC3,1 for peak velocity was 0.792 with a 
95% confidence interval from 0.472 to 0.941(F(9,27)=4.990, p<0.001).  These findings 
support a high degree of agreement across time for the damaging sprint protocol. Table 
2 describes the peak and average velocities for the first three sprints of the repeated 
sprint protocol and the three sprints of the post-damage evaluations, while Table 3 
describes the peak and average velocity change scores for each experimental session. 
Table 2. Sprint Performance 
Variable   Visit 2 Visit 4 Visit 6 Visit 8 
Peak Velocity (m/s) Pre 6.45±0.38 6.39±0.39 6.38±0.41 6.38±0.41 
  Post 6.36±0.37 6.44±0.43 6.36±0.39 6.45±0.34 
Avg Velocity (m/s) Pre 4.71±0.25 4.74±0.25 4.71±0.21 4.76±0.21 
  Post 4.51±0.29* 4.68±0.30* 4.58±0.25* 4.60±0.30* 
Values are mean ± SD. Pre = average of the first three sprints of the repeated sprint protocol (visits 2, 
4, 6, and 8). Post = average of the three sprints of the post-damage protocol evaluations (visits 3, 5, 7, 
and 9). 
*indicates significant difference from Pre. 
 
Table 3. Velocity Change Scores 
Variable Visits 2&3 Visits 4&5 Visits 6&7 Visits 8&9 
Peak Velocity (m/s) 1.28±4.70 -0.88±2.90 0.06±6.84 -1.57±8.48 
Avg Velocity (m/s) 4.15±5.92 1.29±2.03 2.84±1.87 3.53±4.09 
Values are mean ± SD. Values indicate a decline in velocity, expressed as a percent difference of 
the average of the first three sprints of the repeated sprint protocol (visits 2, 4, 6, and 8) and the 
average of the three sprints of the post-damage protocol evaluations (visits 3, 5, 7, and 9. No 
significant differences were observed for peak (p=0.685) or average (p=0.345) velocities. 
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 The two-way repeated measures ANOVA compared average and peak velocities 
across time for the average of the first three sprints of the repeated sprint protocol 
during trials 2, 4, 6, and 8 and the average of the three sprints of visits 3, 5, 7, and 9. 
Average velocity showed no main effect for trial (p=0.507) and no significant 
interaction effect for trial*time (p=0.344). However, there was a significant main effect 
for time (p=0.002), indicating that average velocity significantly decreased from the 
repeated sprint protocol to the post-damage evaluations. When peak velocity was 
analyzed, there were no significant main effects for trial (p=0.874) or time (p=0.937), 
and no significant interaction for trial*time (p=0.699). 
 Pearson’s correlations were conducted to compare velocity metrics to player 
load and lactate measurements. Average velocity did not correlate with total player load 
(r= -0.132, p=0.416), average player load (r=-0.143, p=0.378), relative player load 
(r=0.121, p=0.457), IP lactate (r=-0.294, p=0.065), or 3P lactate (r=-0.226, p=0.161).  
Maximum velocity did not correlate with total player load (r= 0.083, p=0.611), average 
player load (r=0.069, p=0.672), relative player load (r=0.100, p=0.541), IP lactate 
(r=0.054, p=0.739), or 3P lactate (r=-0.005, p=0.975). However, a moderate, positive 
correlation between average and maximum velocity (r=0.465, p=0.003) was noted. 
Player Load 
 Figures 3, 4, and 5 represent each of the three player load metrics (total, relative, 
and average player load) across all four testing visits.  
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Values are mean ± SD. Total player load is the sum of player load of all sprints, expressed in arbitrary 
units (AU). No statistically significant differences were observed between visits 2, 4, 6, and 8 (p=0.331). 
 
Values are mean ± SD. Relative player load = total player load relative to body weight (kg). No 










































Figure 3. Mean total player load across visits 2, 4, 6, and 8. 
Figure 4. Mean relative player load across visits 2, 4, 6, and 8. 
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Values are mean ± SD. Average player load = the player load incurred during each individual sprint. No 
statistically significant differences were observed between visits 2, 4, 6, and 8 (p=0.358). 
 
A one-way repeated measures ANOVA was conducted to compare total player  
load, average player load (player load per sprint), and relative player load (player 
load/kg) across all four trials.  The Greenhouse-Geisser correction was utilized 
following a statistically significant finding on Mauchly’s test of sphericity, revealing 
equal variance of differences for all pairs could not be assumed.  There were no 
significant differences between trials for total player load (p=0.331), player load per 
sprint (p=0.358), or relative player load (p=0.309).  
Pearson’s correlations were conducted to determine if player load measurements 
were related to post-sprinting lactate values. Total player load was positively correlated 
with IP lactate (r=0.386, p=0.014) and 3P lactate (r=0.548, p<0.001). Average player 

























Figure 5. Mean values for average player load across visits 2, 4, 6, and 8. 
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Pearson’s Correlations were also performed to compare perceived upper, lower, 
and total body soreness to total and relative player load measures. A significant positive 
correlation was observed between visit 4 total player load and visit 5 total body soreness 
(r=0.684, p=0.029) as well as between visit 4 total player load and visit 5 lower body 
soreness (r=0.777, p=0.008). 
Countermovement Jump Metrics 
 One-way ANOVA with repeated measures were conducted to compare CMJ 
variables across the four experimental sessions and the four post-damage evaluations to 
determine is significant differences existed. Two-way, trial*time repeated measures 
ANOVA were utilized to compare CMJ performance prior to the damaging sprint 
protocol (visits 2,4,6,8) and to the concomitant follow up trial (visit 3,5,7,9). Table 4 
represents CMJ metrics of interest as means ± SD, and Table 5 represents change scores 
as a percent decrease from baseline values following the EIMD protocol. PPr, ConRFD, 
ConMP, EccMP, ConPF, and EccPF are expressed relative to body weight, while 
ConMF and EccMF are absolute values. 
 There were no significant differences in the percent decline between visits 2 and 
3, 4 and 5, 6 and 7, or 8 and 9 for PPr (p=0.802), ConRFD (p=0.652), ConMP 
(p=0.892), EccMP (p=0.285), ConPF (p=0.721), EccPF (p=0.588), ConMF (p=0.196), 
EccMF (p=0.377), ConIMP (0.201), ConTPF (0.576), and FTCT (p=0.198). These 
findings indicate that participants experienced similar declines in jump performance 
following each EIMD protocol. 
 Results of the two-way ANOVA indicated that there were no trial*time 
interactions for PPr (p=0.714), ConRFD (p=0.455), ConMP (p=0.773), EccMP 
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(p=0.535), ConPF (p=0.649), EccPF (p=0.598), ConMF (p=0.222), EccMF (p=0.360), 
ConIMP (p=0.262), ConTPF (p=0.223), or FTCT (p=0.215). No significant trial effects 
were observed for PPr (p=0.850), ConRFD (p=0.272), ConMP (p=0.299), EccMP 
(p=0.133), ConPF (p=0.168), EccPF (p=0.552), ConMF (p=0.431), (p=0.518), ConIMP 
(p=0.251), ConTPF (p=0.649), or FTCT (p=346). However, a significant time effect did 
exist for some CMJ variables.  Pairwise comparisons with Bonferroni corrections 
revealed that PPr (p=0.006), ConRFD (p=0.001), ConMP (p<0.001), EccMP (p=0.002), 
ConPF (p<0.001), EccPF (p=0.001), ConMF (p<0.001), and ConIMP (p=0.046), 
demonstrated a decreased performance between baseline and post-damage protocol 
values. No significant time effects were observed for EccMF (p=0.148),  ConTPF 
(p=0.756) or FTCT (p=0.059). 
38 
Table 4. Countermovement Jump Metrics 
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Exercise Performance and CMJ  
 Pearson’s correlations were conducted to compare FTCT declines and Sdec and 
one-way repeated measures ANOVA compared performance decrement measures 
between visits 2, 4, 6, and 8. FTCT measures did not significantly correlate with Sdec 
(r=0.10, p=0.950). FTCT declines were not significantly different between all visits 
(p=0.098). Sdec was not significantly different between visits (p=0.246).  
 Additionally, one-way repeated measures ANOVA was also used to compare 
FTCT declines, as well as, Sdec across all follow-up visits. There were no significant 
differences between visits 3, 5, 7, and 9 for FTCT (p=0.166). 
Blood Lactate 
 A 4 (trial) x 3 (time) repeated measures ANOVA was conducted to compare 
blood lactate values between visits for pre-sprinting, immediately post-sprinting, and 
three-minutes post-sprinting lactate levels. Values can be found in Table 5. 
Table 5. Blood Lactate 
 
 There was no interaction effect for trial*time main effect for trial indicating 
lactate levels were consistent across all visits (p>=0.784).  However, there was a main 
effect for time (p<0.001).  Post-hoc testing was performed to reveal where significant 
 Variable Visit 2 Visit 4 Visit 6 Visit 8 
Pre (mmol/L) 1.61±0.64 1.44±0.57 1.56±0.53 1.44±0.25 
IP (mmol/L) 5.88±2.36a,b 5.21±2.39a,b 6.10±2.82a,b 5.36±2.55a,b 
3P (mmol/L) 4.41±2.10a 4.12±2.23a 4.66±2.28a 4.12±2.25a 
Values are mean ± SD. Pre = baseline. IP = immediately post. 3P = 3-minutes post. 
aindicates significant difference from Pre  
bindicates significant difference from 3P 
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differences existed.  Mean values ± SD can be seen in Figure 6 across all time points for 
all EIMD sprinting visits.  Bonferroni pairwise comparisons showed that visit 2, IP 
(p<0.001) and 3P (p=0.001) were significantly greater than pre-sprinting values, and IP 
was significantly greater than 3P (p=0.028). For visit 4, IP (p=0.003) and 3P(p=0.020) 
were significantly greater than pre, and IP was significantly greater than 3P (p=0.001). 
For visit 6, IP (p=0.004) and 3P (p=0.013) was significantly greater than pre, and IP 
was significantly greater than 3P (p=0.001). For visit 8, IP (p=0.003) and 3P (p=0.016) 





 Upper, lower, and total body soreness results can be seen in Figures 7, 8, and 9, 
respectively. A one-way repeated measures ANOVA was performed to compare upper 
body, lower body, and total body soreness following repeated sprint activity (visits 3, 5, 
7, 9). There was no significant difference between time points for upper body 
(p=0.136), lower body (p=0.124), or total body soreness (p=0.176). Separate one-way 
Values are mean ± SD. Pre = baseline. IP = immediately post. 3P = 3-minutes post. 






























Figure 6. Mean lactate values at Pre, IP, and 3P across visits 2, 4, 6, and 8. 
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ANOVAs were conducted to compare upper, lower, and total body soreness for each 
visit. No significant difference was found between upper, lower, and total body areas 
for visit 3 (p=0.146), visit 5 (p=0.062), visit 7 (p=0.258), or visit 9 (p=0.136). However, 
because no significant differences were found, all measurements were collapsed, and a 
single one-way ANOVA was performed. The results indicated that total body soreness 
(p=0.014) and lower body soreness (p<0.001) were both significantly greater than upper 
body soreness. Lower body and total body soreness were not significantly different 
(p=0.898). Pearson’s correlations revealed that total body soreness had a strong, 
positive correlation to lower body (r=0.839, p<0.001) and upper body (r=0.677, 
p<0.001) soreness. Lower body and upper body soreness had a weak, positive 
correlation (r=0.362, p=0.022). 
Figure 7. Upper Body Soreness 
 
Values are mean ± SD. Soreness ratings are measured on a scale from 0-10. *indicates a            






















Figure 8. Lower Body Soreness 
 
Values are mean ± SD. Soreness ratings are measured on a scale from 0-10. *indicates a            
significant difference from baseline measures (p£0.05). 
 
Figure 9. Total Body Soreness 
 
Values are mean ± SD. Soreness ratings are measured on a scale from 0-10. *indicates a            




 A 4 (trial) x 2 (condition) ANOVA was conducted to compare RPE immediately 
post (IP) and 30-minutes post (30P) across visits 2, 4, 6, and 8. A condition effect was 














































statistically significant. Bonferroni pairwise comparisons indicated that RPE-IP was 
significantly greater than RPE-30P (p=0.009). RPE-IP was not significantly different 
across all four visits (p=0.416). RPE-30P was not significantly different across all four 
visits (p=0.102). RPE mean values across all time points are illustrated in Figure 10. 
Values are mean ± SD. IP = immediately post. 30P = 30-minutes post. RPE values are measured using the 









































Figure 10. Mean RPE for IP and 30P time points across visits 2, 4, 6, and 8. 
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Chapter 5: Discussion 
 The purpose of the study was to evaluate the use of a sprinting protocol to 
consistently generate exercise-induced muscle damage using an active female 
population, and to observe how jumping metrics and sprint performance change due to 
muscle damage. It was hypothesized that: 1) there would be a decline in sprint 
performance during the repeated sprint protocol, 2) there would be a significant 
relationship between fatigue characteristics of repeated sprinting and countermovement 
jumps, 3) there would be a significant relationship between sprinting metrics and 
countermovement jump metrics during the repeated sprint protocol, and 4) sprint 
velocity and player load would have a significant relationship with repeated sprint 
ability and lactate clearance. 
Sprint Performance 
 Results showed that peak velocity and average velocity between visits 2, 4, 6, 
and 8 were not significantly different. This lack of significance was expected due to the 
sprint-trained nature of the participants and supports the absence of a learning effect or 
training effect across trials. Additionally, ICC3,1 values were shown to be high, 
indicating that there was a strong level of agreement between experimental trials for 
both peak velocity and average velocity. Average velocity was significantly lower 
following the muscle damage protocol for all follow-up visits occurring 24-48 hours 
later. This agrees with previous work (1, 12, 13, 14) as the reductions in sprint 
performance are most likely the result of EIMD-induced decreases in force production, 
considered a hallmark effect of this condition. However peak velocity achieved did not 
decrease, but the two variables were moderately correlated to each other. This may 
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indicate that the force loss due to muscle damage diminished the acceleration phase 
where the largest requirement for force production is required and thus delayed rather 
than prevented the participants from reaching their peak velocities.  
Percent change scores were also similar for both average and peak velocity, 
which may suggest that the reduction in performance was stable across all experimental 
trails. This finding shows that participants were able to function at the same level each 
visit as they completed four EIMD protocols within a 30-day period, which suggests 
that all participants recruited were highly trained. This high training status may explain 
why RBE interference was not observed or points to the stability of the RBE in trained 
females once it occurs. 
 Sprint performance did not demonstrate the expected correlations to total player 
load, average player load, or relative player load. The expected outcome was that 
increasing sprint velocity would be associated with an increased player load. A possible 
explanation for the lack of agreement could be that player load is calculated from 
accelerometer-based data but considers all athlete movements in the X, Y, and Z planes 
including arm swings, lateral motion, and up and down movements throughout the 
duration of each sprint, while radar data only includes linear velocity on a fixed target 
and extraneous movements are removed during data filtering. The study cohort had a 
varied running efficiency; therefore, each participant’s player load was likely influenced 
more so by differences in running economy and mechanics than by sprint velocity. 
Player Load 
 Player load is a value derived through quantification of changes in inertia and 
used to quantify the intensity of a training session or competition through the 
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examination of an individual’s movement patterns or external work (18). These derived 
values have arbitrary units and can be used to evaluate both acute and chronic bouts of 
exercise (32).  Player load metrics from the current study were not different across all 
four visits, which indicated that participants achieved similar intensities and workloads 
during each muscle damage protocol.  This is a key finding that points to the 
participants’ ability to replicate effort and the consistency of their run technique. 
 Total and average player load were correlated with post-test lactate 
measurements. Player load is a validated method of quantifying external training load 
(18, 42) and blood lactate is a valid means of measuring internal response to an imposed 
external demand (55). Previous work has examined the relationship between external 
and internal training load (56) but has not used blood lactate as an internal measurement 
for comparison. The current findings indicate that player load might be used in place of 
blood lactate in order to non-invasively quantify physiological workload during training 
or competition or used in conjunction with lactate analysis to better understand how an 
individual may respond to changes in training that impose an increased or differing 
external work load.  Since individuality in training responses are common, the 
combination of these two outcome variables may provide valuable information and thus 
be warranted. 
 Correlation between total player load and total body soreness, as well as 
between total player load and lower body soreness were found, but only during visits 4 
and 5. Previous literature (61) has shown that external training load was significantly 
related to athlete soreness using male rugby players, however the external training load 
was derived utilizing a modified sRPE method.  While both correlations in the current 
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study were strong, the lack of any other significance between player load and soreness 
indicates that further research is required to determine if an association truly exists. 
Countermovement Jump Metrics 
 Countermovement jumps (CMJ) were used to assess force output, as previous 
work has shown that CMJ testing is the best jump test to assess neuromuscular function 
due to high sensitivity to change and high repeatability in both acute and chronic 
exercise (23, 29). These works support the findings of the current study, as CMJ 
variables of interest were not significantly different from each other between visits 2, 4, 
6, and 8, indicating that the participants gave similar effort and produced consistent 
CMJ during each testing session.  
 Results from the current investigation revealed that several of the CMJ force and 
power variables of interest (PPr, ConRFD, ConMP, EccMP, ConPF, EccPF, ConMF, 
ConIMP) decreased in the visits following the repeated sprint protocol. These findings 
agree with McLean et al. (52) who found that neuromuscular performance measures 
such as relative power output are reduced for at least 48 hours following repeated sprint 
sports. The results showed that participants exhibited decreased force generating 
capacity indicative of exercise-induced muscle damage during the post-damage protocol 
evaluations, consistent with the findings of others (51). This suggests that the current 
protocol is not only a valid means of eliciting EIMD similar to previous work (1, 12, 13, 
14) but it is also reproducible, as force decrements were not eliminated due to the 
repeated bout effect (14). The observed changes in ConTFP indicate that participants 
were slower at reaching peak force following the repeated sprint protocol, which could 
be detrimental during competition when maximal neuromuscular effort is required. A 
48 
2016 study by Martinez (53) stated that an 8% decline in the ratio of flight time to 
contraction time was a strong predictor of declines in athlete readiness, slow stretch-
shortening cycle (SSC) activity, and neuromuscular fatigue than traditional jump testing 
as they account for changes in jump strategy in order to maintain jump height. Observed 
declines in FTCT ratio in the current study ranged from -2.2% to -7.5%, indicating that 
either the subjects could not maintain their pre-damage flight time or required a longer 
period of time (time under tension) for contraction to elicit a similar flight time.  In 
either case, these changes seem indicative of a reduction in force-producing capacity of 
the lower body musculature. 
Exercise Performance and CMJ 
 Analysis of FTCT and Sdec scores determined that sprinting and jumping 
declines were similar between trials 2, 4, 6, and 8. This finding suggests that 
participants did not experience attenuated force loss due to the repeated bout effect. The 
Sdec formula used to determine decrement in sprint performance was determined by 
Glaister et al. (58) to be the best method of quantifying fatigue during repeated sprints. 
The inclusion of every sprint time in the calculation of the formula accounts for noise in 
the measurements due to biological variability, as well as unexplained speed increases 
during the final sprint (58, 59). The Sdec formula appears to be a valuable method for 
analyzing reduction in sprint performance over multiple attempts and thus warrants use 
in future studies. 
Sprinting is an exercise that produces a very high RFD, requires a large amount 
of energy, and is considered a fast SSC movement (50). Countermovement jumps are 
classified as slow SSC movements (49) that place low physiological strain on 
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participants (27), allowing them to be used in conjunction with the repeated sprint 
protocol without significant contribution to overall fatigue. However, CMJ performance 
was not correlated to sprint performance in the current study. This finding does not 
agree with previous literature (40, 59) which states that CMJ can be used as a predictor 
of sprint performance. However, it should be noted that the present study attempted to 
correlate performance decrements rather than predict maximal performance. 
Additionally, decrements in both sprint performance and CMJ performance were 
observed in post-damage protocol visits. 
Blood Lactate 
 An accumulation of blood lactate, commonly associated with fatigue, occurs 
when metabolic energy demand causes an increased reliance on glycolysis, resulting in 
a shift in the balance between production and removal (54). Blood lactate values were 
not significantly different between visits for any time points, indicating that participants 
experienced a similar internal physiological response for each muscle damage protocol. 
The increase from pre to IP measurements indicated that the 40 sprints induced a high 
physiological load similar to what would be expected in an interval training session or 
repeated sprint sports (47). The significant difference between IP and 3P values 
indicated that the participants had already experienced significant clearance in the first 
three minutes following the protocol. This finding supports the assumption that 
participants were well trained. Training has been shown to increase an athlete’s ability 
to clear lactate rather than reducing production (57). The current study did not control 
for menstrual cycle during the testing sessions. However, a study by Smekal et al. (48) 
found no effect on blood lactate by menstrual cycle phase in female participants. 
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Perceived Soreness 
VAS ratings of DOMS, which is one of the most common symptoms indicative 
of EIMD (1, 7, 12, 14), showed that participants experienced significant levels of upper, 
lower, and total body soreness following each testing session, and that lower and total 
body soreness were higher than upper body. The indicated levels of soreness were not 
significantly different between each post-damage evaluation, which indicates that the 
participants experienced similar levels of perceived damage after each testing session. 
Lower body and total body measures were not significantly different from each other 
and were strongly correlated.  
Session RPE 
 No differences in sRPE were indicated between visits 2, 4, 6, and 8 for IP or 30P 
time points, indicating that participants viewed the intensity of the repeated sprint 
protocol similarly across all four visits. These findings agree with Foster et al. (43), who 
indicated that sRPE was a reliable means of evaluating exercise intensity. The present 
findings also support Pustina et al. (45), who stated that sRPE is a strong indicator of 








Chapter VI: Conclusion 
Key Findings 
 The purpose of this study was to evaluate the use of a sprinting protocol as a 
consistent field-based means of generating EIMD in a well-trained female population, 
as well as to observe changes in sprinting and jumping metrics due to incurred muscle 
damage. Additionally, this study sought to examine the relationship between sprint 
velocity and player load, and to determine how they relate to repeated sprint ability and 
lactate clearance. Through this investigation, it was concluded that the protocol was a 
valid and reliable means of eliciting EIMD, with measurable decrements in both 
sprinting and jumping performance for up to 24-48 hours following the completion of 
the protocol. Although a significant relationship between fatigue characteristics of 
repeated sprinting and CMJ performance did not occur, both exhibited decrements in 
post-exercise evaluations that are indicative of muscle damage that could hinder 
performance. Sprint performance and player load were not significantly related, but 
player load was shown to be associated with lactate levels following repeated sprints. 
The practical significance of the current study is that sports teams could use this 
protocol to evaluate fatigue characteristics for their athletes and utilize CMJ metrics or 
sprint decrement scores to determine an athlete’s readiness for competition.  
Limitations 
 Several limitations exist in this study. The reduction in the participant pool due 
to attrition may have reduced the potential to find some significant relationships 
between variables due to a reduced variability.  However, the a priori power analysis 
was based on the variables with the smallest expected treatment effect and highest 
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variability in order to reduces chances for Type II error.  The researchers feel the study 
was sufficiently powered as evidenced by the significance findings of the study and the 
size of the subject cohorts typical of this type of investigation in the literature.   
Participation in previous sporting events may have exposed participants to 
eccentric loading, diminishing the effects of the EIMD protocol. Muscle fiber typing 
was not used in the current investigation, as differences in fiber type composition may 
have impacted soreness due to preferential recruitment of Type II muscle fibers during 
eccentric contractions.  
A menstrual history was included to ensure that participants were experiencing 
normal cycling, but the phase of menstrual cycle was not standardized. Finally, testing 
was performed indoors to eliminate external confounding variables, so velocity data 
could not be collected from the Catapult units for comparison to radar gun velocities, 
however the radar gun used for the current study is considered the “gold standard” for 
measurements of linear velocity and used to establish criterion validity when testing 
advanced timing gate systems.   
Future Research Directions 
 Future research should examine recovery modalities that might be utilized to 
attenuate force loss so that athletes may streamline the process of returning to peak 
performance capacity. Future studies may also investigate the critical power and critical 
rest interval needed to preserve sprint ability in repeated sprint sports. Finally, because 
sport involves sprints with short deceleration and immediate change of direction, future 
research could investigate the decline in performance related to eccentrically biased 
change-of-direction movements performed in a repeated trial manner and with the use 
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of a timing gate system to capture changes at different distance intervals that may shed 
light on how peak velocities are maintained over the entirety of distance and how 
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